PMID
Data
Article Title
Organization
Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.

Northwestern University
 
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies.

University of Chieti&Quot;G. D'Annunzio&Quot
 
2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.

Northwestern University
 
Novel 2,4-disubstituted pyrimidines as potent, selective, and cell-permeable inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
Structure-based design of bacterial nitric oxide synthase inhibitors.

University of California
 
Combination of chiral linkers with thiophenecarboximidamide heads to improve the selectivity of inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity.

Northwestern University
 
Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.

Northwestern University
 
Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma.

Northwestern University
 
An Accessible Chiral Linker to Enhance Potency and Selectivity of Neuronal Nitric Oxide Synthase Inhibitors.

Northwestern University
 
Chiral linkers to improve selectivity of double-headed neuronal nitric oxide synthase inhibitors.

Northwestern University
 
In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.

Northwestern University
 
Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins.

University of California
 
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Northwestern University
 
Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.

University of California
 
Structure-guided design of selective inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.

Nycomed
 
Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.

Neuraxon
 
1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.

Neuraxon
 
Synthesis, biological evaluation and molecular docking studies of 3-(triazolyl)-coumarin derivatives: effect on inducible nitric oxide synthase.

Universidade De S£O Paulo
 
NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with ยต-Opioid Agonist Activity.

TBA
 
First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.

Neuraxon
 
Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).

Neuraxon
 
Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain.

Neuraxon
 
Synthesis and evaluation of pyrido[1,2-a]pyrimidines as inhibitors of nitric oxide synthases.

Christian-Albrechts-University of Kiel
 
N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system.

Christian-Albrechts-University of Kiel
 
Discovery of a series of aminopiperidines as novel iNOS inhibitors.

Adolor
 
Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors.

Neuraxon
 
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.

Merck Research Laboratory
 
Substituted 6-phenyl-pyridin-2-ylamines: selective and potent inhibitors of neuronal nitric oxide synthase.

Pfizer
 
5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors.

Pfizer
 
Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.

Northwestern University
 
Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.

Astrazeneca R&D Charnwood
 
Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.

Northwestern University
 
Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor.

Pfizer
 
Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases.

Northwestern University
 
N(omega)-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).

Pfizer
 
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.

Pfizer
 
N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.

Glaxo Wellcome Research and Development
 
Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine.

Northwestern University
 
Selective inhibition of neuronal nitric oxide synthase by N omega-nitroarginine-and phenylalanine-containing dipeptides and dipeptide esters.

Northwestern University
 
Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity.

Glaxo Wellcome Research and Development
 
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms.

G. D. Searle Research and Development
 
Approaches toward selective inhibition of nitric oxide synthase.

University of Michigan
 
Novel inhibitors of neuronal nitric oxide synthase with potent antioxidant properties.

Institut Henri Beaufour
 
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors.

Schering
 
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine.

Glaxo Wellcome Research and Development
 
1H-pyrazole-1-carboxamidines: new inhibitors of nitric oxide synthase.

Northwestern University
 
Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors.

Neuraxon
 
Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.

Neuraxon
 
Novel inhibitors of nitric oxide synthase with antioxidant properties.

University of Catania
 
Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors.

Afraxis
 
Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.

Neuraxon
 
Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors.

Kalypsys
 
1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.

Neuraxon
 
1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.

Neuraxon
 
Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase.

Northwestern University
 
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNO

Kalypsys
 
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.

Glaxosmithkline
 
Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives.

Northwestern University
 
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase.

Università
 
Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase.

Northwestern University
 
Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.

Northwestern University
 
Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.

Northwestern University
 
Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase.

Universita G. D'Annunzio
 
 
Inhibition of nitric oxide synthase by benzoxazolones

TBA
 
 
Conformationally restricted arginine analogues as inhibitors of human nitric oxide synthase

TBA
 
 
1,2-diaminobenzimidazoles : Selective inhibitors of nitric oxide synthase derived from aminoguanidine

TBA
 
Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase.

Washington University
 
Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability.

Northwestern University
 
Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.

Northwestern University
 
Inhibitory effects of a series of 7-substituted-indazoles toward nitric oxide synthases: particular potency of 1H-indazole-7-carbonitrile.

Université
 
Advances in nitric oxide regulators for the treatment of ischemic stroke.

China Pharmaceutical University
 
Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel enzyme inhibitors modulating the nitric oxide pathway.

Flinders University
 
Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors.

Northwestern University
 
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer.

University of Granada
 
Selective L-nitroargininylaminopyrrolidine and L-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors.

Northwestern University
 
Conformationally restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors.

Northwestern University
 
Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases.

Sanofi-Aventis
 
Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes.

Nagoya City University
 
2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors.

Northwestern University
 
Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase.

Merck Research Laboratories
 
Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases.

Merck Research Laboratories
 
Optimization of 

China Pharmaceutical University
 
2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution.

Astrazeneca R&D Charnwood
 
Structure-activity relationships of potent, selective inhibitors of neuronal nitric oxide synthase based on the 6-phenyl-2-aminopyridine structure.

Pfizer
 
Fluorinated dihydroquinolines as potent n-NOS inhibitors.

Schering
 
3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor.

Pharmacia
 
Dihydroquinolines as novel n-NOS inhibitors.

Schering
 
Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines.

Fukui Research Institute
 
Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase.

Pharmacia
 
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation.

University "G. D'Annunzio" of Chieti-Pescara
 
Thienopyridines: nitric oxide synthase inhibitors with potent in vivo activity.

Astrazeneca R&D Charnwood
 
3,4-Dihydro-1-isoquinolinamines: a novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency.

Astrazeneca R&D Charnwood
 
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.

Merck Research Laboratories
 
Guanidine-substituted imidazoles as inhibitors of nitric oxide synthase.

Wake Forest University Winston-Salem
 
Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: structure-activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor.

Julius-Maximilians University WüRzburg
 
Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.

Northwestern University
 
A new class of selective and potent inhibitors of neuronal nitric oxide synthase.

Pfizer
 
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.

University of Hradec Kralove
 
Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.

Wake Forest University
 
First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.

Northwestern University
 
Nitroaromatic amino acids as inhibitors of neuronal nitric oxide synthase.

Abbott Laboratories
 
Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase.

Searle
 
Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.

G. D. Searle Research and Development
 
Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers.

Washington University
 
Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.

Northwestern University
 
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.

University of Chieti "G. D'Annunzio
 
Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.

Northwestern University
 
Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.

Northwestern University
 
Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.

Northwestern University
 
Adenosine A3 receptor modulators

Palobiofarma
 
Multitarget FAAH and COX inhibitors and therapeutical uses thereof

Fondazione Istituto Italiano Di Tecnologia
 
Compounds and compositions as inhibitors of MEK

Novartis
 
Compounds for the treatment of hepatitis C

Bristol-Myers Squibb
 
Triazolopyridazine

Boehringer Ingelheim International
 
Pharmaceutical composition for treating diabetes

Ajinomoto
 
Management and treatment of benign prostatic hyperplasia

CSIR, Pretoria (Za)
 
Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase.

Genentech
 
Screening of selective inhibitors of 1a,25-dihydroxyvitamin D3 24-hydroxylase using recombinant human enzyme expressed in Escherichia coli.

University of Wisconsin
 
Novel selective thiol inhibitors of neutral endopeptidase containing heterocycles at P'2 position.

R & D, Zambon Group
 
Alpha-1 adrenergic receptor binding in aortas from rat and dog: comparison of [3H]prazosin and beta-iodo-[125I]-4-hydroxyphenyl-ethyl-aminomethyl-tetralone.

Unwersity of Misscuri
 
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo.

Vertex Pharmaceuticals
 
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.

Glaxosmithkline
 
Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.

Glaxosmithkline